These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1335941)

  • 1. VIP inhibits CCK-induced gallbladder contraction involving a beta-adrenoceptor mediated pathway in the rainbow trout, Oncorhynchus mykiss, in vivo.
    Aldman G; Holmgren S
    Gen Comp Endocrinol; 1992 Nov; 88(2):287-91. PubMed ID: 1335941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efffect of vasoactive intestinal polypeptide on gallbladder smooth muscle in vitro.
    Ryan JP; Ryave S
    Am J Physiol; 1978 Jan; 234(1):E44-6. PubMed ID: 623247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of vasoactive intestinal polypeptide and cholecystokinin octapeptide on the control of gallbladder contraction.
    Strah KM; Melendez RL; Pappas TN; Debas HT
    Surgery; 1986 Apr; 99(4):469-73. PubMed ID: 3952671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraduodenal fat and amino acids activate gallbladder motility in the rainbow trout, Oncorhynchus mykiss.
    Aldman G; Holmgren S
    Gen Comp Endocrinol; 1995 Oct; 100(1):27-32. PubMed ID: 8575655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vasoactive intestinal polypeptide on basal and cholecystokinin-induced gallbladder pressure.
    Ryan J; Cohen S
    Gastroenterology; 1977 Oct; 73(4 Pt 1):870-2. PubMed ID: 892388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of rainbow trout gallbladder contraction by cionin, an ancestral member of the CCK/gastrin family.
    Schjoldager B; Jørgensen JC; Johnsen AH
    Gen Comp Endocrinol; 1995 Jun; 98(3):269-78. PubMed ID: 7628686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of canine gallbladder motility by brain peptides.
    Lenz HJ; Zimmerman FG; Messmer B
    Gastroenterology; 1993 Jun; 104(6):1678-85. PubMed ID: 8500726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vagal nerves and peptides in the control of extrahepatic biliary motility. An experimental study in the cat.
    Dahlstrand C
    Acta Physiol Scand Suppl; 1990; 589():1-52. PubMed ID: 1700577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cholecystokinine on the gallbladder motility: interaction with somatostatin and vasoactive intestinal peptide.
    Milenov K; Rakovska A; Kalfin R
    Acta Physiol Pharmacol Bulg; 1995; 21(3):67-76. PubMed ID: 8868369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duodenal acidification and intra-arterial injection of CCK8 increase gallbladder motility in the rainbow trout, Oncorhynchus mykiss.
    Aldman G; Grove D; Holmgren S
    Gen Comp Endocrinol; 1992 Apr; 86(1):20-5. PubMed ID: 1505726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actions of VIP, somatostatin, and pancreatic polypeptide on gallbladder tension and CCK-stimulated gallbladder contraction in vitro.
    Lonovics J; Devitt P; Rayford PL; Thompson JC
    Surg Forum; 1979; 30():407-9. PubMed ID: 538649
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of vasoactive intestinal polypeptide (VIP) on the canine gallbladder motility.
    Kalfin R; Milenov K
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1991; 100(3):513-7. PubMed ID: 1687549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous vasoactive intestinal peptide (VIP) on gallbladder function in the cat.
    Jansson R; Steen G; Svanvik J
    Gastroenterology; 1978 Jul; 75(1):47-50. PubMed ID: 401095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of action of cholecystokinin in the canine gastrointestinal tract: role of vasoactive intestinal peptide and nitric oxide.
    Vergara P; Woskowska Z; Cipris S; Fox-Threlkeld JE; Daniel EE
    J Pharmacol Exp Ther; 1996 Oct; 279(1):306-16. PubMed ID: 8859008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of endogenous cholecystokinin on postprandial gallbladder refilling. Ultrasonographic study in healthy subjects and in gallstone patients.
    Cicala M; Corazziari E; Diacinti D; Badiali D; Torsoli A
    Dig Dis Sci; 1995 Jan; 40(1):76-81. PubMed ID: 7821124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mu-Opiate receptor agonist loperamide blocks bethanechol-induced gallbladder contraction, despite higher cholecystokinin plasma levels in man.
    Otto B; Mawe GM; Riepl RL
    Neurogastroenterol Motil; 2005 Oct; 17(5):761-6. PubMed ID: 16185316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction.
    Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P
    Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gallbladder muscle dysfunction in patients with chronic acalculous disease.
    Amaral J; Xiao ZL; Chen Q; Yu P; Biancani P; Behar J
    Gastroenterology; 2001 Feb; 120(2):506-11. PubMed ID: 11159891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.
    Parkman HP; Pagano AP; Ryan JP
    Am J Physiol; 1997 Jun; 272(6 Pt 1):G1433-8. PubMed ID: 9227479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.